These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7052133)

  • 1. Characterization and partial purification of the plasminogen activator from human neuroblastoma cell line, SK-N-SH. A comparison with human urokinase.
    Gilbert LC; Wachsman JT
    Biochim Biophys Acta; 1982 Jun; 704(3):450-60. PubMed ID: 7052133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of human kidney plasminogen activator dissimilar to urokinase.
    Sueishi K; Nanno S; Okamura T; Inoue S; Tanaka K
    Biochim Biophys Acta; 1982 Aug; 717(2):327-36. PubMed ID: 7052141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and properties of a plasminogen activator from cultured rat prostate adenocarcinoma cells.
    Strickland DK; de Serrano VS; Chan SY; Pollard M; Castellino FJ
    Biochemistry; 1983 Sep; 22(19):4444-9. PubMed ID: 6684952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and purification of plasminogen activator from Yoshida ascites Sarcoma of rats.
    Nulkar MW; Pawse AR
    Indian J Biochem Biophys; 1991 Feb; 28(1):46-51. PubMed ID: 1905268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin.
    Kasai S; Arimura H; Nishida M; Suyama T
    J Biol Chem; 1985 Oct; 260(22):12377-81. PubMed ID: 3930494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial purification and characterization of keratokinase, the fibrinolytic activator of the cornea.
    Pandolfi M; Lantz E
    Exp Eye Res; 1979 Nov; 29(5):563-71. PubMed ID: 393529
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasminogen-activator in human early milk: its partial purification and characterization.
    Okamoto U; Horie N; Nagamatsu Y; Yamamoto JI
    Thromb Haemost; 1981 Apr; 45(2):121-6. PubMed ID: 7196095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of a urokinase-type plasminogen activator (Mr = 54,000) from cultured human endothelial cells indistinguishable from urinary urokinase.
    Booyse FM; Osikowicz G; Feder S; Scheinbuks J
    J Biol Chem; 1984 Jun; 259(11):7198-205. PubMed ID: 6539333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covalent molecular weight approximately 92 000 hybrid plasminogen activator derived from human plasmin amino-terminal and urokinase carboxyl-terminal domains.
    Robbins KC; Tanaka Y
    Biochemistry; 1986 Jun; 25(12):3603-11. PubMed ID: 2941075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urokinase-like plasminogen activators of unusually high molecular weight secreted by a cell line derived from a human lung cancer case.
    Harvey S; Minowada J; Takita H; Kover L; Markus G
    J Biol Chem; 1982 May; 257(10):5645-51. PubMed ID: 7040369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue culture.
    Holmberg L; Lecander I; Persson B; Astedt B
    Biochim Biophys Acta; 1978 Nov; 544(1):128-37. PubMed ID: 152655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures.
    Stump DC; Lijnen HR; Collen D
    J Biol Chem; 1986 Jan; 261(3):1274-8. PubMed ID: 3080423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid purification of a high-affinity plasminogen activator from human blood plasma by specific adsorption on fibrin/Celite.
    Husain SS; Lipinski B; Greuwich V
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4265-9. PubMed ID: 6270665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of human vascular plasminogen activator.
    Aasted B
    Biochim Biophys Acta; 1980 Feb; 621(2):241-54. PubMed ID: 7188733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on a plasminogen activating system in human milk: IV. Difference in the binding to fibrin between human milk plasminogen activator (mild activator) and urokinase (author's transl)].
    Horie N
    Nihon Ketsueki Gakkai Zasshi; 1979 Oct; 42(5):38-45. PubMed ID: 396753
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrin binding and zymogenic properties of single-chain urokinase (pro-urokinase).
    Gurewich V; Pannell R
    Semin Thromb Hemost; 1987 Apr; 13(2):146-51. PubMed ID: 3114882
    [No Abstract]   [Full Text] [Related]  

  • 17. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
    Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
    J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of single-chain urokinase-type plasminogen activator (pro-urokinase) from human A431 cells.
    Corti A; Nolli ML; Soffientini A; Cassani G
    Thromb Haemost; 1986 Oct; 56(2):219-24. PubMed ID: 3101222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial purification and characterization of native plasminogen activators from bovine milk.
    Deharveng G; Nielsen SS
    J Dairy Sci; 1991 Jul; 74(7):2060-72. PubMed ID: 1894805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and fibrin-binding properties of different molecular forms of pro-urokinase from a monkey kidney cell culture.
    Wijngaards G; Rijken DC; van Wezel AL; Groeneveld E; van der Velden CA
    Thromb Res; 1986 Jun; 42(6):749-60. PubMed ID: 3088754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.